Delivery Order SPE2DB20D2104-SPE2DB24FU54U

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,283.49 firm fixed-price delivery order is for the supply of 4,566,178,214 units of doxycycline hyclate 100 mg capsules. The contract has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,563,619,033 units of Doxycycline Hyclate 100 mg capsules. The fixed-price delivery order, valued at $1,350.96, has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,445.80, is for the delivery of 4,563,267,851 units of Doxycycline Hyclate 100 mg capsules. The contract has a completion date of January 9, 2024 and was awarded on January 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific award is for the delivery of 4,563,076,964 capsules of Doxycycline Hyclate 100 mg, a generic antibiotic medication. The contract...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,358.93, is for the delivery of 4,566,846,892 units of Doxycycline Hyclate 100 mg tablets with an ultimate completion date of January 7, 2025. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,135.70 firm fixed-price delivery order is for the supply of 4,566,882,298 units of Doxycycline Hyclate 100 mg tablets with an ultimate completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,895.03 firm fixed price contract is for the delivery of 4,566,895,400 doxycycline 50 mg tablets. The contract has an ultimate completion date of January 13, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,074,952 units of Doxycycline Hyclate 100mg tablets. The $2,209.34 firm fixed-price contract has a period of performance through February 28, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,724.32, is for the delivery of 4,567,201,863 units of Doxycycline Hyclate 100 mg tablets, with a period of performance through February 10, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,630.73 firm fixed-price delivery order is for the provision of 4,559,305,900 units of Doxycycline Hyclate 100 mg tablets, with a completion date of December 8, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB24FU54U
    Delivery Order

This contract award is for the delivery of 4,564,816,084 units of doxycycline monohydrate 100mg capsules to the Defense Logistics Agency (DLA). The $1,194.81 firm fixed-price delivery order has a completion date of June 6, 2024 and was awarded on June 5, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:11 AM